BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 21763284)

  • 1. miR-29c targets TNFAIP3, inhibits cell proliferation and induces apoptosis in hepatitis B virus-related hepatocellular carcinoma.
    Wang CM; Wang Y; Fan CG; Xu FF; Sun WS; Liu YG; Jia JH
    Biochem Biophys Res Commun; 2011 Aug; 411(3):586-92. PubMed ID: 21763284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-98-5p Inhibits Tumorigenesis of Hepatitis B Virus-Related Hepatocellular Carcinoma by Targeting NF-κB-Inducing Kinase.
    Fei X; Zhang P; Pan Y; Liu Y
    Yonsei Med J; 2020 Jun; 61(6):460-470. PubMed ID: 32469170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of miR-520e-mediated MAPK signalling pathway on HBV replication and regulation of hepatocellular carcinoma cells via targeting EphA2.
    Tian JH; Liu WD; Zhang ZY; Tang LH; Li D; Tian ZJ; Lin SW; Li YJ
    J Viral Hepat; 2019 Apr; 26(4):496-505. PubMed ID: 30521133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-122 inhibits viral replication and cell proliferation in hepatitis B virus-related hepatocellular carcinoma and targets NDRG3.
    Fan CG; Wang CM; Tian C; Wang Y; Li L; Sun WS; Li RF; Liu YG
    Oncol Rep; 2011 Nov; 26(5):1281-6. PubMed ID: 21725618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-22 is down-regulated in hepatitis B virus-related hepatocellular carcinoma.
    Shi C; Xu X
    Biomed Pharmacother; 2013 Jun; 67(5):375-80. PubMed ID: 23582783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-222-3p induced by hepatitis B virus promotes the proliferation and inhibits apoptosis in hepatocellular carcinoma by upregulating THBS1.
    Sun Y; Shi P; Wu Q; Liu B; Yu Z; Jia H; Chang H
    Hum Cell; 2021 Nov; 34(6):1788-1799. PubMed ID: 34273068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5.
    Cao Y; Chen J; Wang D; Peng H; Tan X; Xiong D; Huang A; Tang H
    Oncotarget; 2015 Nov; 6(35):38093-106. PubMed ID: 26497554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional analysis of miR-181a and Fas involved in hepatitis B virus-related hepatocellular carcinoma pathogenesis.
    Zou C; Chen J; Chen K; Wang S; Cao Y; Zhang J; Sheng Y; Huang A; Tang H
    Exp Cell Res; 2015 Feb; 331(2):352-61. PubMed ID: 25449696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-29a promotes hepatitis B virus replication and expression by targeting SMARCE1 in hepatoma carcinoma.
    Wu HJ; Zhuo Y; Zhou YC; Wang XW; Wang YP; Si CY; Wang XH
    World J Gastroenterol; 2017 Jul; 23(25):4569-4578. PubMed ID: 28740345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-19a, miR-122 and miR-223 are differentially regulated by hepatitis B virus X protein and involve in cell proliferation in hepatoma cells.
    Yu G; Chen X; Chen S; Ye W; Hou K; Liang M
    J Transl Med; 2016 May; 14(1):122. PubMed ID: 27150195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The miR-545/374a cluster encoded in the Ftx lncRNA is overexpressed in HBV-related hepatocellular carcinoma and promotes tumorigenesis and tumor progression.
    Zhao Q; Li T; Qi J; Liu J; Qin C
    PLoS One; 2014; 9(10):e109782. PubMed ID: 25299640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA F11-AS1 inhibits HBV-related hepatocellular carcinoma progression by regulating NR1I3 via binding to microRNA-211-5p.
    Deng Y; Wei Z; Huang M; Xu G; Wei W; Peng B; Nong S; Qin H
    J Cell Mol Med; 2020 Jan; 24(2):1848-1865. PubMed ID: 31880390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-29c-3p regulates DNMT3B and LATS1 methylation to inhibit tumor progression in hepatocellular carcinoma.
    Wu H; Zhang W; Wu Z; Liu Y; Shi Y; Gong J; Shen W; Liu C
    Cell Death Dis; 2019 Jan; 10(2):48. PubMed ID: 30718452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-802 induces hepatitis B virus replication and replication through regulating SMARCE1 expression in hepatocellular carcinoma.
    Wang Y; Cao J; Zhang S; Sun L; Nan Y; Yao H; Fan J; Zhu LY; Yu L
    Cell Death Dis; 2019 Oct; 10(10):783. PubMed ID: 31611549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B virus mRNAs functionally sequester let-7a and enhance hepatocellular carcinoma.
    Deng M; Hou J; Hu J; Wang S; Chen M; Chen L; Ju Y; Li C; Meng S
    Cancer Lett; 2016 Dec; 383(1):62-72. PubMed ID: 27693636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-185-5p suppresses HBV gene expression by targeting ELK1 in hepatoma carcinoma cells.
    Fan HX; Feng YJ; Zhao XP; He YZ; Tang H
    Life Sci; 2018 Nov; 213():9-17. PubMed ID: 30308183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B Virus-Encoded MicroRNA (HBV-miR-3) Regulates Host Gene PPM1A Related to Hepatocellular Carcinoma.
    Chavalit T; Nimsamer P; Sirivassanametha K; Anuntakarun S; Saengchoowong S; Tangkijvanich P; Payungporn S
    Microrna; 2020; 9(3):232-239. PubMed ID: 31686644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of microRNA-210-3p in hepatitis B virus-related hepatocellular carcinoma.
    Morishita A; Fujita K; Iwama H; Chiyo T; Fujihara S; Oura K; Tadokoro T; Mimura S; Nomura T; Tani J; Yoneyama H; Kobayashi K; Kamada H; Guan Y; Nishiyama A; Okano K; Suzuki Y; Himoto T; Shimotohno K; Masaki T
    Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G401-G409. PubMed ID: 31905024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of MicroRNA-145 Caused by Hepatitis B Virus X Protein Promotes Expression of CUL5 and Contributes to Pathogenesis of Hepatitis B Virus-Associated Hepatocellular Carcinoma.
    Gao F; Sun X; Wang L; Tang S; Yan C
    Cell Physiol Biochem; 2015; 37(4):1547-59. PubMed ID: 26512974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A suppressive role of ionizing radiation-responsive miR-29c in the development of liver carcinoma via targeting WIP1.
    Wang B; Li D; Sidler C; Rodriguez-Juarez R; Singh N; Heyns M; Ilnytskyy Y; Bronson RT; Kovalchuk O
    Oncotarget; 2015 Apr; 6(12):9937-50. PubMed ID: 25888625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.